FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/02/2026
Back to search
Official data from USPTO
VIVIBEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
04/03/2026
Trademark type
Combined
Nice classes
1, 5, 29, 30
Filing date
02/08/2022
Registration date
09/02/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/02/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
IT
Examiner
COUGHLAN, REBECCA D.
Law office
M40
Current location
GENERIC WEB UPDATE
Mark description
The trademark consists of an imprint depicting the wording "VIVIBEN" in fancy characters, preceded by a stylized twig bearing three stylized leaves and flanked with three stylized oval figures.
Holders and representatives
Holders
FRAU PHARMA S.R.L.
Representatives
Keith A. Weltsch Scully, Scott, Murphy & Presser, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 29Class 30
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical additives for use in the manufacture of food products; vitamins for use in the manufacture of food products; chemical additives for use in the manufacture of food as enrichment of food composition; vitamins for use in the manufacture of food as enrichment of food composition; chemical productschemical additives to be used in the manufacture of food supplements; chemical productschemical additives to be used in the manufacture of pharmaceuticals and veterinary products; vitamins to be used in the manufacture of pharmaceutical and veterinary products; oleoylethanolamide to be used in the production of food and reinforced food; oleoylethanolamide to be used in the production of pharmaceutical and veterinary products; oleoylethanolamide to be used in the production of medical food; oleoylethanolamide to be used in the production of dietary ingredients in the nature of dietary supplements and food supplements; oleoylethanolamide and palmitoylethanolamide combination for use in the production of pharmaceutical and veterinary products; oleoylethanolamide and palmitoylethanolamide combination for use in the production of food and medical food; oleoylethanolamide and palmitoylethanolamide combination for use in the production of food supplements; oleoylethanolamide and palmitoylethanolamide combination used in the manufacture of dietary ingredients in the nature of dietary supplements; anandamide for use in the production of medical food; anandamide for use in the production of food supplements; anandamide for use in the production of pharmaceutical products; combination of oleoylethanolamidepalmitoylethanolamideanandamide for use in the production of foodmedical foodfood supplementsdietary ingredientspharmaceutical and veterinary products; anandamide with purity from 10 percent to 99 percent for use in the production of foodmedical foodfood supplementsdietary ingredientspharmaceutical and veterinary products; oleoylethanolamide with purity from 10 percent to 99 percent for use in the production of foodmedical foodfood supplementsdietary ingredientspharmaceutical and veterinary products; spermidinesperminealiphatic polyamine used in the production of food and medical food; spermidinesperminealiphatic polyamine to be used in the production of pharmaceutical and veterinary products; spermidinesperminealiphatic polyamine used in the production of food supplements and dietary ingredients; spermidinesperminealiphatic polyamine used in the manufacture of food to reinforce or enrich foodfood extract and fermented food; polyamines and acyl ethalonammides combination for use in the production of foodfood supplementspharmaceuticalsdietary products in the nature of dietary supplements; phosphatidylserinephosphatidylcholinephosphatidylethanolaminephosphatidylenositol as single entity to be used in the manufacture of foodmedical foodfood supplementspharmaceuticalveterinary products; natural phospholipids (PSPCPEPI) and acyl ethanolammides combination in powder form and in oil dispersion or emulsion for use in the manufacture of medical foodfood supplements; combination of natural phospholipids (PSPCPEPI)spermidinespermine in powder form and in oil dispersion or emulsion for use in the manufacture of medical foodfood supplements; combination of natural phospholipids (PSPCPEPI)L (-) methyl tetraidofolic acid or its salts in powder and fluid form for use in the manufacture of medical foodfood supplements; natural lecithynes added with spermidinespermine and other natural aliphnatic polyamines in powder and oil form for use in the manufacture of medical foodfood supplements; natural lecithynes added with L (-) methyl tetraidofolic acid and or folic acid in powder and oil form for use in the manufacture of medical foodfood supplements; any hemp in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; none of the foregoing goods containing CBD
Class 5
Nutraceuticals for use in therapeutical dietsfor the treatment of inflammationcardiological conditionsdiabetesobesity or overweight people; nutraceuticals for use as dietary supplements; vitamin preparations; dietetic foodsbakery goods adapted for medical purposes; wheat germ dietary supplements; dietary supplements for animals; food supplements containing folic acidmethyltetrahydrofolic acidL (-) methyl tetraidofolic acid and its salts; nutraceutical preparations for medical purposesto be used to improve the quality of life of oncological patientsfor the treatment of cancer; pharmaceutical products for use by human beingsocular pharmaceuticals; veterinary productsdietary supplement nutraceuticalsamino acids and biological preparations for veterinary purposes for the treatment of cancer; dietetic foods adapted for medical use; dietary supplements for human beings and animals; dietary food supplements for medical use containing oleoylethanolamidepalmithoylethanolamideanandamidespermidinesperminephosphatidylserinenatural phospholipidsL (-) methyltetrahydrofolic acid and its saltsadded or enriched with the above chemical nutrients to improve the nutritional value or the health benefitseventually added with other products excipientsprocessing aids used in human or animal diet; any hemp in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; none of the foregoing goods containing CBD
Class 29
Animal fats for food; blended oil for food; soya milk; yogurt; breakfast yogurt; milk; cheese; fermented milk; goat milk; powdered milk; processed shell fruits; condensed milk; food products made from meatfishpoultry and gamemeat-based snack foodsfish-based snack foods; food products made from fruits and vegetablesdried fruits and vegetablespreserved fruits and vegetablescooked fruits and vegetables; all of the foregoing goods featuring palmithoylethanolamideoleoylethanolamideanandamidepoliaminesspermidinesperminephosphatidylserinebeing addedalone and natural phospholipid in combination with the aforementioned goods; any hemp in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; none of the foregoing goods containing CBD
Class 30
Chocolate; ice cream; biscuits; breakfast cereals; pizzas; bakery goods; rice; popcorn; soya flour; starch-based thickeners for whipped cream; flour; bread; pastries; frozen confectionery; fruit jellies being candies; baking powder; cooking salt; food products made from riceflour and cerealsriceflour and processed cereals with added folic acidmethyltetrahydrofolic acidL (-) methyltetrahydrofolic acid and its saltsfolic acid derivates; food products being pastrypetit fours and confectionery made of sugar; all of the foregoing goods featuring palmithoylethanolamideoleoylethanolamideanandamidepoliaminesspermidine and spermine phosphatidylserinebeing addedalonenatural phospholipid in combination with the aforementioned goods; any hemp in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; none of the foregoing goods containing CB
Publications
History of USPTO decisions and trademark events.
35 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/16/2026
FIMP
FINAL DISPOSITION PROCESSED
03/16/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/02/2025
CHPN
POST PUBLICATION AMENDMENT – NOT ENTERED
10/07/2025
APET
ASSIGNED TO PETITION STAFF
10/06/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/02/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
09/02/2025
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
08/26/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/15/2025
PUBO
PUBLISHED FOR OPPOSITION
07/15/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/09/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/12/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
06/12/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/12/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
06/12/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/03/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/03/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/03/2025
RFNT
REFUSAL PROCESSED BY IB
12/21/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/03/2024
RFRR
REFUSAL PROCESSED BY MPU
12/03/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/26/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/07/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/07/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/14/2023
CNRT
NON-FINAL ACTION WRITTEN
08/14/2023
DOCK
ASSIGNED TO EXAMINER
01/17/2023
DOCK
ASSIGNED TO EXAMINER
12/08/2022
DOCK
ASSIGNED TO EXAMINER
11/21/2022
MAFR
APPLICATION FILING RECEIPT MAILED
09/13/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/07/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
09/06/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/01/2022
Continuous trademark protection
Get notified about every new filing that threatens VIVIBEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.